Investors Capital Advisory Services’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
BBHC
Investors Capital Advisory Services's NVS Position: Q2 2016 in Review
Investors Capital Advisory Services increased its Novartis (NVS) stake by 6% in Q2 2016, buying an estimated $25.7K and bringing the position to 6,543 shares worth $483K. The position accounts for 0.09% of the portfolio, ranked #290.
Investors Capital Advisory Services first reported a position in NVS in Q3 2014 and has held it in 8 quarters since. The position peaked at $524K in Q4 2015. 879 funds tracked by Wall St. Rank hold NVS as of Q2 2016.
- Investors Capital Advisory Services held 6,543 shares of Novartis worth $483K as of Q2 2016.
- Investors Capital Advisory Services bought 372 Novartis shares in Q2 2016, an estimated $25.7K.
- Novartis made up 0.09% of Investors Capital Advisory Services's portfolio in Q2 2016, its #290 holding.
- Investors Capital Advisory Services first reported a position in Novartis in Q3 2014 and has held it in 8 quarters since.
- Investors Capital Advisory Services's Novartis position peaked at $524K in Q4 2015.
- 879 funds tracked by Wall St. Rank held Novartis as of Q2 2016.
Based on Investors Capital Advisory Services's 13F filing for Q2 2016, filed 2 Aug 2016.